Clinical trial I4D-MC-JTJN
A Phase 2 Study of Prexasertib in Platinum-Resistant or Refractory Recurrent Ovarian Cancer
Cancers | |
---|---|
Organ | Ovary |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 2 |
Academic trial | Non |
Sponsor | Lilly |
EudraCT Identifier | 2017-004009-42 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03414047 |
Inclusion criteria | Platinium resistant |
Last update |